How did doctors get it so wrong for 20 years?

How did doctors get it so wrong for 20 years? That's how long Made In Chelsea star Jane complained of fatigue and aching joints...

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody...

Market access restrictions for high efficacy Multiple Sclerosis therapies may be hindering their ability to optimally treat their clinically complex, relapsing patients, according to...
video

Talking about Ocrevus (Ocrelizumab)

The Rocky Mountain Multiple Sclerosis Center is a patient and family-centered nonprofit organization that provides a comprehensive and integrated wellness approach to MS and...

Roche seeks partners for remyelination therapies

Roche Holding AG is seeking a partner with experimental drugs that might help repair the damage caused to the nervous system by multiple sclerosis...

Health Canada approval last week of multiple sclerosis drug ‘absolutely a game-changer’

Global News - Joseph Petrilli said he cried for a long time when he heard that Health Canada approved a new drug that could...
video

How I kept faith after losing my baby boy – Living with Multiple Sclerosis

Life comes at you fast.I never expected to face some of life’s most challenging moments — all in the course of three years:Being diagnosed with...

Using Statin’s in multiple sclerosis treatment

Scientists are hopeful a major drug trial will establish that statins can be used to treat multiple sclerosis.The low-cost drugs are typically prescribed to...

Biogen’s 8% Increase to Some MS Medications Could Provide a Boost in 2018

Market Watch reports Biogen Inc.'s BIIB, +4.90% recent price increases on multiple sclerosis drugs "could provide lift into '18," according to RBC Capital Markets...

Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS

SOURCE Novartis- Breakthrough Therapy designation can expedite the development and review of therapies for serious conditions- In a pivotal Phase III study, oral fingolimod...
video

Introducing the Barts MS Charity – “Lets Find Answers Together”

What is the objective of Barts MS Charity?To enable Barts-MS to undertake hard-to-fund, or to prime important, MS research projects.Our first key objective is to...

Social Media

834FollowersFollow